Jeffrey Rade to Risk Assessment
This is a "connection" page, showing publications Jeffrey Rade has written about Risk Assessment.
Connection Strength
0.381
-
Rade JJ, Kronsberg SS, Kickler TS, Vasan RS, Xanthakis V, Nayor MG, Barton BA. Association of Systemic Thromboxane Generation With Risk of Developing Heart?Failure. J Am Coll Cardiol. 2025 Jan 07; 85(1):58-70.
Score: 0.149
-
Kakouros N, Nazarian SM, Stadler PB, Kickler TS, Rade JJ. Risk Factors for Nonplatelet Thromboxane Generation After Coronary Artery Bypass Graft Surgery. J Am Heart Assoc. 2016 Mar 15; 5(3):e002615.
Score: 0.081
-
McLean RC, Nazarian SM, Gluckman TJ, Schulman SP, Thiemann DR, Shapiro EP, Conte JV, Thompson JB, Shafique I, McNicholas KW, Villines TC, Laws KM, Rade JJ. Relative importance of patient, procedural and anatomic risk factors for early vein graft thrombosis after coronary artery bypass graft surgery. J Cardiovasc Surg (Torino). 2011 Dec; 52(6):877-85.
Score: 0.060
-
Rade JJ, Hogue CW. Do we really need another biomarker to diagnose myocardial infarction after coronary artery bypass graft surgery? Anesth Analg. 2010 Nov; 111(5):1086-7.
Score: 0.056
-
Hariri E, Lessard D, Gore J, Rade J, Goldberg R. Are We Optimizing the Use of Dual Antiplatelet Therapy in Patients Hospitalized with Acute Myocardial Infarction? Cardiovasc Revasc Med. 2020 02; 21(2):182-188.
Score: 0.025
-
Gluckman TJ, Rade JJ, Schulman SP. The value of clopidogrel administered postoperatively following a non-ST-segment elevation acute coronary syndrome. Chest. 2005 Jun; 127(6):2297.
Score: 0.010